{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:44:25Z","timestamp":1783377865643,"version":"3.54.6"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12328-024-02053-3","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T11:02:44Z","timestamp":1729594964000},"page":"161-168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A case of successful conversion surgery for unresectable gallbladder cancer treated with durvalumab in combination with gemcitabine plus cisplatin"],"prefix":"10.1007","volume":"18","author":[{"given":"Tatsuhiro","family":"Araki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Muranushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruyoshi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuto","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaku","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0625-1911","authenticated-orcid":false,"given":"Tsutomu","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"key":"2053_CR1","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.21873\/invivo.13274","volume":"37","author":"A Ibuki\u0107","year":"2023","unstructured":"Ibuki\u0107 A, Rami\u0107 S, Zovak M, et al. Expression and prognostic significance of PD-L1 and NY-ESO1 in gallbladder carcinoma. In Vivo. 2023;37:1828\u201337.","journal-title":"In Vivo"},{"key":"2053_CR2","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s11605-017-3440-z","volume":"21","author":"TB Tran","year":"2017","unstructured":"Tran TB, Norton JA, Ethun CG, et al. Gallbladder cancer presenting with jaundice: uniformly fatal or still potentially curable? J Gastrointest Surg. 2017;21:1245\u201353.","journal-title":"J Gastrointest Surg"},{"key":"2053_CR3","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1097\/SLA.0b013e318216f5f3","volume":"253","author":"H Nishio","year":"2011","unstructured":"Nishio H, Ebata T, Yokoyama Y, et al. Gallbladder cancer involving the extrahepatic bile duct is worthy of resection. Ann Surg. 2011;253:953\u201360.","journal-title":"Ann Surg"},{"key":"2053_CR4","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273\u201381.","journal-title":"N Engl J Med"},{"key":"2053_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/jjco\/hyv213","volume":"46","author":"J Mizusawa","year":"2016","unstructured":"Mizusawa J, Morizane C, Okusaka T, et al. Randomized phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan clinical oncology group study (JCOG1113, FUGA-BT). Jpn J Clin Oncol. 2016;46:385\u20138.","journal-title":"Jpn J Clin Oncol"},{"key":"2053_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/jhbp.1219","volume":"30","author":"T Ioka","year":"2023","unstructured":"Ioka T, Kanai M, Kobayashi S, et al. Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA). J Hepatobiliary Pancreat Sci. 2023;30:102\u201310.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2053_CR7","doi-asserted-by":"publisher","first-page":"EVIDoa2200015","DOI":"10.1056\/EVIDoa2200015","volume":"1","author":"DY Oh","year":"2022","unstructured":"Oh DY, Ruth He A, Qin S, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid. 2022;1:EVIDoa2200015.","journal-title":"NEJM Evid"},{"key":"2053_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ags3.12434","volume":"5","author":"R Matsuyama","year":"2021","unstructured":"Matsuyama R, Yabusita Y, Homma Y, et al. Essential updates 2019\/2020: surgical treatment of gallbladder cancer. Ann Gastroenterol Surg. 2021;5:152\u201361.","journal-title":"Ann Gastroenterol Surg"},{"key":"2053_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.14701\/ahbps.22-075","volume":"27","author":"ABH Bhatti","year":"2023","unstructured":"Bhatti ABH, Dar FS, Riyaz S, et al. Survival after extended resections for gallbladder cancer. Ann Hepatobiliary Pancreat Surg. 2023;27:70\u20135.","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"2053_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/bjs.10401","volume":"104","author":"Y Yamamoto","year":"2017","unstructured":"Yamamoto Y, Sugiura T, Ashida R, et al. Indications for major hepatectomy and combined procedures for advanced gallbladder cancer. Br J Surg. 2017;104:257\u201366.","journal-title":"Br J Surg"},{"key":"2053_CR11","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/ags3.12713","volume":"7","author":"I Nakamura","year":"2023","unstructured":"Nakamura I, Hatano E, Baba H, et al. Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer. Ann Gastroenterol Surg. 2023;7:1009\u201320.","journal-title":"Ann Gastroenterol Surg"},{"key":"2053_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13000-023-01318-8","volume":"18","author":"C Liu","year":"2023","unstructured":"Liu C, Fang F, Kong Y, et al. Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring. Diagn Pathol. 2023;18:48.","journal-title":"Diagn Pathol"},{"key":"2053_CR13","doi-asserted-by":"publisher","first-page":"e255403","DOI":"10.1136\/bcr-2023-255403","volume":"16","author":"S Zhang","year":"2023","unstructured":"Zhang S, Nie J, Tai S, et al. PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer. BMJ Case Rep. 2023;16:e255403.","journal-title":"BMJ Case Rep"},{"key":"2053_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.14701\/ahbps.2019.23.4.403","volume":"23","author":"M Prieto","year":"2019","unstructured":"Prieto M, Gastaca M, Ruiz P, et al. Long term recurrence free survival in a stage IV gallbladder cancer treated with chemotherapy plus trastuzumab and salvage liver resection. Ann Hepatobiliary Pancreat Surg. 2019;23:403\u20137.","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"2053_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.14701\/ahbps.2021.25.3.349","volume":"25","author":"MY Oh","year":"2021","unstructured":"Oh MY, Kim H, Choi YJ, et al. Conversion surgery for initially unresectable extrahepatic biliary tract cancer. Ann Hepatobiliary Pancreat Surg. 2021;25:349\u201357.","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"2053_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40792-022-01406-9","volume":"8","author":"Y Wakasa","year":"2022","unstructured":"Wakasa Y, Toyoki Y, Kusumi T, et al. Conversion surgery following gemcitabine plus cisplatin therapy for initially unresectable gallbladder cancer with peritoneal carcinomatosis: a case report. Surg Case Rep. 2022;8:50.","journal-title":"Surg Case Rep"},{"key":"2053_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13256-021-03248-9","volume":"16","author":"M Inoue","year":"2022","unstructured":"Inoue M, Hakoda K, Sawada H, et al. Locally advanced gallbladder cancer treated with effective chemotherapy and subsequent curative resection: a case report. J Med Case Rep. 2022;16:30.","journal-title":"J Med Case Rep"},{"key":"2053_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40792-022-01375-z","volume":"8","author":"Y Miura","year":"2022","unstructured":"Miura Y, Ashida R, Sugiura T, et al. Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report. Surg Case Rep. 2022;8:20.","journal-title":"Surg Case Rep"},{"key":"2053_CR19","doi-asserted-by":"publisher","first-page":"107694","DOI":"10.1016\/j.ijscr.2022.107694","volume":"100","author":"F Al Jaber","year":"2022","unstructured":"Al Jaber F, Almaher E, Al-Ibrahim R, et al. Curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: case report and review of literature. Int J Surg Case Rep. 2022;100:107694.","journal-title":"Int J Surg Case Rep"},{"key":"2053_CR20","doi-asserted-by":"publisher","first-page":"977963","DOI":"10.3389\/fonc.2022.977963","volume":"12","author":"Z Yang","year":"2022","unstructured":"Yang Z, Wu Z, Xiong Y, et al. Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy. Front Oncol. 2022;12:977963.","journal-title":"Front Oncol"},{"key":"2053_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40792-023-01664-1","volume":"9","author":"C Takagi","year":"2023","unstructured":"Takagi C, Sato M, Tomita M, et al. Induction chemotherapy and hepatic artery embolization followed by extended resection for locally advanced gallbladder cancer: a case report. Surg Case Rep. 2023;9:79.","journal-title":"Surg Case Rep"},{"key":"2053_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/jhbp.1190","volume":"30","author":"A Hamad","year":"2023","unstructured":"Hamad A, Aquina CT, Ansari A, et al. Impact of delay in adjuvant therapy for gallbladder adenocarcinoma. J Hepatobiliary Pancreat Sci. 2023;30:212\u201320.","journal-title":"J Hepatobiliary Pancreat Sci"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02053-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-024-02053-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02053-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:17:09Z","timestamp":1738329429000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-024-02053-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2053"],"URL":"https:\/\/doi.org\/10.1007\/s12328-024-02053-3","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}